[E-Daily Starin KIM HYUNSIK Reporter] New Order Entertainment has urged caution regarding social media accounts impersonating its artist HYNN (real name Park Hye-won). (Photo courtesy of New Order Entertainment)In a statement released on the 18th, New Order Entertainment explained, “We have recently discovered instances of individuals impersonating HYNN by creating usernames that closely resemble her official account,” adding, “These impersonator accounts are engaging in malicious behavior, such as sending direct messages (DMs) to fans individually or requesting money and personal information.” The agency continued, “Under no circumstances do our artists reach out to fans personally via private messaging apps or social media accounts, nor do they ever ask for money, valuables, or personal information,” and urged caution, saying, “If you receive a message from an account suspected of impersonation, please do not reply to the message or click on any links; instead, block and report the account immediately.” HYNN, who debuted in 2018, has released songs such as “Like Watering a Wilted Flower” and “Casually, Goodbye.” She recently released a new mini-album titled “Summer Texture,” featuring “3 Days Later” as the title track. New Order Entertainment stated, “If you have been harmed by an impersonation account or have discovered one, we would appreciate it if you could report it to our official email address along with a screenshot,” adding, “We will continue to do our best to protect the artist’s rights and interests.”
“The key point in the Jensen Huang scandal will ultimately be that data centers were built in China and elsewhere, and cloud services were provided to Chinese companies. Given the circumstances, this …
“I hear that a major conglomerate is set to launch a soju-beer mix can—a blend of Terra Beer and Chamisul—in the soju-beer can market that we’ve worked so hard to pioneer.”This is a handwritten post t…
Resolute announced to the U.S. Securities and Exchange Commission (SEC) on the 14th (local time) that it had completed patient enrollment for the Phase 3 clinical trial of “Ersodetug.” (Source: U.S. S…